Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.
暂无分享,去创建一个
Hans-Jürgen Thiesen | Oliver Schmitt | Bernd Gerber | M. Glocker | T. Reimer | H. Thiesen | B. Gerber | O. Schmitt | Claudia Röwer | Björn Ziems | Anngret Radtke | Toralf Reimer | Cornelia Koy | Michael O Glocker | B. Ziems | C. Koy | C. Röwer | A. Radtke
[1] F. Pontén,et al. The Impact of Tissue Fixatives on Morphology and Antibody-based Protein Profiling in Tissues and Cells , 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[2] K. Tomer,et al. MALDI/MS-based epitope mapping of antigens bound to immobilized antibodies , 2002, Molecular biotechnology.
[3] F. Pontén,et al. The Human Protein Atlas—a tool for pathology , 2008, The Journal of pathology.
[4] Welch Bl. THE GENERALIZATION OF ‘STUDENT'S’ PROBLEM WHEN SEVERAL DIFFERENT POPULATION VARLANCES ARE INVOLVED , 1947 .
[5] S. Leung,et al. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study , 2008, Breast Cancer Research.
[6] A. Leong,et al. Quantitation in immunohistology: fact or fiction? A discussion of variables that influence results. , 2004, Applied immunohistochemistry & molecular morphology : AIMM.
[7] John McCafferty,et al. Expression profiling by high-throughput immunohistochemistry. , 2004, Journal of immunological methods.
[8] John W. Tukey,et al. Exploratory Data Analysis. , 1979 .
[9] Peter Woollard,et al. A Community Standard Format for the Representation of Protein Affinity Reagents* , 2009, Molecular & Cellular Proteomics.
[10] R M Levenson,et al. Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II , 2006, Histopathology.
[11] Walter Schubert,et al. Topological proteomics, toponomics, MELK-technology. , 2003, Advances in biochemical engineering/biotechnology.
[12] M. Glocker,et al. Mass Spectrometric Characterization of Protein Structure Details Refines the Proteome Signature for Invasive Ductal Breast Carcinoma , 2011, Journal of the American Society for Mass Spectrometry.
[13] Isabelle Salmon,et al. Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis , 2009, Proteomics.
[14] W. Remmele,et al. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.
[15] Carolina Wählby,et al. Bright-field microscopy visualization of proteins and protein complexes by in situ proximity ligation with peroxidase detection. , 2010, Clinical chemistry.
[16] Coralie Apfeldorfer,et al. Object orientated automated image analysis: quantitative and qualitative estimation of inflammation in mouse lung , 2008, Diagnostic pathology.
[17] D. Suckau,et al. Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[19] Stephen M Hewitt,et al. Tissue microarrays enabling high-throughput molecular pathology. , 2007, Current opinion in biotechnology.
[20] K. Scholich,et al. Toponomics: studying protein-protein interactions and protein networks in intact tissue. , 2010, Molecular bioSystems.
[21] Erik K. Malm,et al. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.
[22] Raouf E Nakhleh,et al. Error reduction in surgical pathology. , 2009, Archives of pathology & laboratory medicine.
[23] A Novel Mass Spectrometric Epitope Mapping Approach without Immobilization of the Antibody , 2011 .
[24] Kristina Schwamborn,et al. Molecular imaging by mass spectrometry — looking beyond classical histology , 2010, Nature Reviews Cancer.
[25] Hans-Jürgen Thiesen,et al. Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue , 2009, Analytical and bioanalytical chemistry.
[26] Vilppu J Tuominen,et al. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 , 2010, Breast Cancer Research.
[27] Elston Cw. Classification and grading of invasive breast carcinoma. , 2005 .
[28] C. Elston. Classification and grading of invasive breast carcinoma. , 2005, Verhandlungen der Deutschen Gesellschaft fur Pathologie.
[29] M. Glocker,et al. Rheumatoid Arthritis, a Complex Multifactorial Disease: On the Way Toward Individualized Medicine , 2006 .
[30] Stephen M Hewitt,et al. Validation of proteomic‐based discovery with tissue microarrays , 2008, Proteomics. Clinical applications.
[31] L. McDonnell,et al. Peptide and protein imaging mass spectrometry in cancer research. , 2010, Journal of proteomics.
[32] Gloria Bueno,et al. Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice. , 2010, Folia histochemica et cytobiologica.
[33] D. Ross,et al. Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] J. Kononen,et al. A high‐throughput strategy for protein profiling in cell microarrays using automated image analysis , 2007, Proteomics.